Open AccessInitial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998
Author(s) -
Paul Rivest,
Terry Tannenbaum
Publication year - 2001
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2001/758483
Subject(s) - regimen , ethambutol , medicine , pyrazinamide , tuberculosis , isoniazid , streptomycin , population , odds ratio , surgery , pediatrics , antibiotics , pathology , environmental health , microbiology and biotechnology , biology
To evaluate the proportion of tuberculosis (TB) cases initially treated with the recommended four-drug regimen of isoniazid (INH), rifampin (RIF), pyrazinamide (PZA) and ethambutol (EMB) or streptomycin; and to identify factors associated with the choice of initial therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom